인쇄하기
취소

Pharmas hesitated in developing generics, showing decrease in bioequivalently-tested drugs

Published: 2017-03-06 11:26:44
Updated: 2017-03-06 11:26:44

It was observed there were only 96 pharmaceutical products approved through bioequivalence test this year. This is because pharmaceutical companies are hesitated in developing generic products.

According to the Ministry of Food and Drug Safety(MFDS), the collective number of pharmaceutical products which passed bioequivalence test so far was 10,758 products, including the 96 products approved ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.